Bottom line
IFRAX vs JAAA: the short answer
IFRAX (Voya Floating Rate Fund) and JAAA (Janus Henderson AAA CLO ETF) are both mutual funds.
JAAA is cheaper at 0.2% vs 0.95% — a difference of $75 a year per $10,000 invested.
Over five years, JAAA returned +4.7% a year vs +2.7% for IFRAX (reporting dates differ).
IFRAX has a front-end sales load of up to 2.5%; the other does not.
Updated Nov 19, 2026
IFRAX vs JAAA side by side
| IFRAX | JAAA | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Voya | Janus Henderson |
| Category | Bank Loan / Floating Rate | Bank Loan / Floating Rate |
| Expense ratio | 0.95% | 0.2% |
| Annual cost per $10k | $95 | $20 |
| 10-yr cost on $10k (prospectus) | $1,554 | $255 |
| Max front load | 2.5% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +6.2% | +5.5% |
| 5-yr return (annualized) | +2.7% | +4.7% |
| 10-yr return (annualized) | +2.9% | — |
| Best quarter | +7.7% | +2.6% |
| Worst quarter | −14.8% | −1.8% |
| Net assets (fund) | — | $29.2B |
| Number of holdings | — | 600 |
| Portfolio turnover | 78% | 94% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IFRAX | JAAA | Difference |
|---|---|---|---|
| 2024 | +8.9% | +7.4% | +1.4% |
| 2023 | +11.1% | +8.6% | +2.5% |
| 2022 | −5.1% | +0.5% | −5.6% |
| 2021 | +4.1% | +1.4% | +2.8% |
Source: Fund prospectus bar charts
Holdings overlap
IFRAX and JAAA share none of their top holdings.
IFRAX top 10
JAAA top 10
- Janus Henderson Cash Liquidity Fund LLC — 1.28%
- KKR CLO 35 Ltd. — 0.85%
- AB BSL CLO 1 Ltd. — 0.79%
- Anchorage Capital CLO 16 Ltd. — 0.73%
- Palmer Square CLO Ltd. — 0.68%
- Ares LXI CLO Ltd. — 0.68%
- Carlyle US CLO Ltd. — 0.62%
- WISE CLO Ltd. — 0.62%
- Magnetite XXXII Ltd. — 0.60%
- Carlyle US CLO Ltd. — 0.60%
FAQ
What is the difference between IFRAX and JAAA?
Which is cheaper, IFRAX or JAAA?
Should I own both IFRAX and JAAA?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.